The clinical performance is complex and often involves multi-systematic fatigue. Early identification and standardized diagnosis are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in matching teams of domestic and foreign authoritative experts to provide accurate diagnostic and therapeutic programs. Treatment and management of the anti-synthetic enzyme syndrome involves individual development of therapeutic programs, usually including pharmacotherapy, rehabilitation interventions, regular follow-up, etc. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, significant improvements have been made in many autoimmune and rheumatic immune disorders that have previously been difficult to treat.
Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to the course of treatment. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of acetylsalicylic acid associated with synthetase syndrome. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.